Indirect Inhibition of Toll-like Receptor and Type I Interferon Responses by ITAM-coupled Receptors and Integrins
Overview
Authors
Affiliations
An important function of immunoreceptor tyrosine-based activation motif (ITAM)-coupled receptors is cross-regulation of heterologous receptor signaling, but mechanisms of cross-inhibition are poorly understood. We show that high-avidity ligation of ITAM-coupled beta2 integrins and FcgammaRs in macrophages inhibited type I interferon receptor and Toll-like receptor (TLR) signaling and induced expression of interleukin-10 (IL-10); signaling inhibitors SOCS3, ABIN-3, and A20; and repressors of cytokine gene transcription STAT3 and Hes1. Induction of inhibitors was dependent on a pathway composed of signaling molecules DAP12, Syk, and Pyk2 that coupled to downstream kinases p38 and MSKs and required integration of IL-10-dependent and -independent signals. ITAM-induced inhibitors abrogated TLR responses by cooperatively targeting distinct steps in TLR signaling. Inhibitory signaling was suppressed by IFN-gamma and attenuated in inflammatory arthritis synovial macrophages. These results provide an indirect mechanism of cross-inhibition of TLRs and delineate a signaling pathway important for deactivation of macrophages.
Typhimurium infection inhibits macrophage IFNβ signaling in a TLR4-dependent manner.
Shuster M, Lyu Z, Augenstreich J, Mathur S, Ganesh A, Ling J Infect Immun. 2024; 92(10):e0009824.
PMID: 39269166 PMC: 11475681. DOI: 10.1128/iai.00098-24.
Toll-like receptors and integrins crosstalk.
Alhamdan F, Bayarsaikhan G, Yuki K Front Immunol. 2024; 15:1403764.
PMID: 38915411 PMC: 11194410. DOI: 10.3389/fimmu.2024.1403764.
Typhimurium infection inhibits macrophage IFNβ signaling in a TLR4-dependent manner.
Shuster M, Lyu Z, Augenstreich J, Mathur S, Ganesh A, Ling J bioRxiv. 2024; .
PMID: 38496427 PMC: 10942315. DOI: 10.1101/2024.03.05.583530.
Integrins in Health and Disease-Suitable Targets for Treatment?.
Klaus T, Hieber C, Bros M, Grabbe S Cells. 2024; 13(3.
PMID: 38334604 PMC: 10854705. DOI: 10.3390/cells13030212.
Meyhofer S, Steffen A, Plotze-Martin K, Lange C, Marquardt J, Bruchhage K Immunohorizons. 2023; 7(3):191-199.
PMID: 36921085 PMC: 10563442. DOI: 10.4049/immunohorizons.2300009.